Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : BPRX Turn around -- Ignore unavailable to you. Want to Upgrade?

To: William Minich who wrote (125)	11/6/1997 10:34:00 PM
From: Sinasi Ugraskan	Respond to of 197

BPRX is making money for seven consecutive quarters and will market anti-wrinkle line to boost revenues and earnings in the fourth quarter of 1997. The stock price has risen about 100% within the last month or so. The management has ahigher stake in the success of the company. Their ownership % is higher than some other management in other companies. The book value is at least $1 1/2. EPS is positive and growing. Compared to some other drug companies with negative earnings, BPRX is way underpriced.As more investors look into it, the stock should trade between 3 and 4 by next year in my opinion.